Assay for Inhibitors of HPGD, 15-hydroxyprostaglandin dehydrogenase

项目亮点：针对靶标已经开发和报道了多个探针分子，这些分子的表征正在进行中。

Project highlights: multiple probe molecules have been developed and reported for the target, and characterization of these molecules is ongoing. During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.